Citi analyst Yigal Nochomovitz lowered his price target on Lenz Therapeutics (NASDAQ: LENZ) to $10.00 from $20.00, while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE